Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
NCT06975111
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
What if midlife women, who are inherently at an increased risk for future cardiometabolic disease due to transitioning into menopause, had access to a suite of evidence-based health interventions? Could these interventions reduce menopause-related inflammation, restore a healthier cardiometabolic profile, reverse epigenetic aging, and reduce bothersome menopausal symptoms? The ultimate goal of this work is to attenuate future disease and enhance women's quality of life, extend healthspan and increase productivity.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Menopause
- Menopause Hot Flashes
- Menopause Related Conditions
- Cardiovascular
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2/3
- Ages
- 45 to 55 years
- Sex
- Female
- Healthy volunteers
- Accepted
- Sponsor
- University of Colorado, Denver
- Last updated on ClinicalTrials.gov
- July 21, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- University of Colorado-School of Medicine · Aurora, CO
North Carolina · 1
- University of North Carolina, School of Medicine · Chapel Hill, NC
Virginia · 1
- Virginia Commonwealth University · Richmond, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.